Skip to main content
Scientific Reports logoLink to Scientific Reports
. 2018 Dec 5;8:17676. doi: 10.1038/s41598-018-36149-x

Sodium selenite inhibits deoxynivalenol-induced injury in GPX1-knockdown porcine splenic lymphocytes in culture

Zhihua Ren 1,#, Yu Fan 1,#, Zhuo Zhang 1,#, Chaoxi Chen 2,#, Changhao Chen 1, Xuemei Wang 1, Junliang Deng 1, Guangneng Peng 1, Yanchun Hu 1, Suizhong Cao 1, Shumin Yu 1, Xiaoping Ma 1, Liuhong Shen 1, Zhijun Zhong 1, Ziyao Zhou 1, Zhiwen Xu 1, Zhicai Zuo 1,
PMCID: PMC6281670  PMID: 30518949

Abstract

Deoxynivalenol (DON) is a cytotoxic mycotoxin that can cause cell damages. The main effect is to inhibit protein synthesis. Oxidative stress is one of the effects of DON. Selenium (Se) can ameliorate the cell damage caused by DON-induced oxidative stress, but it is unclear whether through selenoprotein glutathione peroxidase 1 (GPX1). We established GPX1-knockdown porcine spleen lymphocytes, and treated them with DON and Se. Untransfected porcine splenic lymphocytes (group P) and transfected cells (group M, GPX1 knockdown) were treated with or without DON (0.824, 0.412, 0.206, or 0.103 μg/mL, group D1-4), Se (Na2SeO3, 2 μM, group Se), or both (group SD1–4) for 6, 12, or 24 h. The cells were collected and the activities of SOD and CAT, levels of GSH, H2O2, malonaldehyde (MDA), total antioxidant capacity (T-AOC), and the inhibition of free hydroxyl radicals were determined. Levels of ROS were measured at 24 h. Compared with group P, the antioxidant capacity of group M was reduced. DON caused greater oxidative damage to the GPX1-knockdown porcine splenic lymphocytes than to the normal control cells. When Na2SeO3 was combined with DON, it reduced the damage in the GPX1-knockdown porcine splenic lymphocytes, but less effectively than in the normal porcine splenic lymphocytes.

Introduction

Deoxynivalenol (DON) is a stable trichothecene mycotoxin1, so it is difficult to destroy or eliminate during conventional food storage or processing. Therefore, it readily causes zoonoses2. Different species of animals display different tolerance for DON, and pigs are highly sensitive to it3. DON not only reduces the utilization rate of animal feed, but also reduces the growth performance and reproductive performance of animals and destroys their immune systems4. The spleen is the main target when DON affects the immune system. DON affects cell signalling5, interferes with and damages ribosomes2, inhibits the synthesis of proteins and nucleic acids5,6, and promotes cell apoptosis7,8. Oxidative stress is an important mechanism of DON-mediated cytotoxicity and apoptosis9. The main mechanism by which DON induces oxidative stress is by the accumulation of high levels of reactive oxygen species (ROS) in the cell, destroying the cellular oxidation–antioxidant balance10. ROS induce lipid peroxidation in the lipid membrane, damaging its phospholipids and lipoproteins, and causes DNA damage in a chain reaction8,11.

Selenium (Se) is a necessary trace element for animals, including humans12, and is especially required by the immune system13. Selenium has many biological functions, the most important of which is in anti-oxidation. Selenium is the most important component of the glutathione peroxidase (GPX) active centre, selenocysteine, and participates in important processes by inhibiting lipid peroxidation, catalysing the reduction by glutathione (GSH) of toxic peroxides in the body, removing excessive free radicals, and protecting the mechanisms and functions of the cell membrane. A large number of studies have shown that the addition of the proper amount of Se enhances the antioxidant capacity of the body or cell and increases the expression of GPX114. GPX1 also has some preventive effects on the oxidative damage caused by mycotoxins1518.

GPX1 was the first antioxidant enzyme shown to reduce H2O2 in red blood cells via GSH19. It is the most important antioxidant enzyme in the body and is widely expressed during major cell division. It can remove free radicals and peroxide from cells, and together with other antioxidant enzymes (catalase [CAT] and superoxide dismutase [SOD]), constitutes the endogenous antioxidant defence system20,21. An appropriate increase in GPX1 expression can enhance the antioxidant capacity of cells22,23.

Our laboratory has shown that Se can reduce the damage to porcine spleen lymphocytes caused by DON-induced oxidative stress19, and can prevent the concomitant changes in cytokines induced in porcine spleen lymphocytes24. However, it remains unclear whether it antagonizes DON toxicity through the selenoprotein GPX1. In this study, we established GPX1-knockdown porcine spleen lymphocytes and treated them sodium selenite (Na2SeO3) and DON, singly or combined, in a culture system. We then measured the intracellular antioxidant index and the ROS content of the GPX1-knockdown porcine spleen lymphocytes to determine the protective effects of sodium selenite on DON-induced oxidative damage in these cells and whether Se acts through the selenoprotein GPX1 in antagonizing the toxicity of DON.

Results

Transfection efficiency of GPX1-directed small interfering RNA (siRNA) in porcine spleen lymphocytes

The transfection efficiency of GPX1-directed siRNA in porcine spleen lymphocytes is shown in Fig. 1. Transfection efficiency of GPX1-directed siRNA in porcine splenic lymphocytes. the blank control shown in A. In B, C, D, E shown the different transfection efficiency of combination. Combination E has the best transfection effect, we selected combination E for the subsequent experiment.

Figure 1.

Figure 1

Transfection efficiency of GPX1-directed siRNA in porcine splenic lymphocytes. the blank control shown in (A), the transfection efficiency of combination was 51.1% + 0.8% shown in (B), the transfection efficiency of combination was 71.3% + 1.3% shown in (C), the transfection efficiency of combination was 80.6% + 1.7% shown in (D), and the transfection efficiency of combination was 92.9% + 2% shown in (E). Therefore, we selected combination E for the subsequent experiment.

Expression of GPX1 mRNA after siRNA transfection

The relative expression of GPX1 mRNA after siRNA transfection is shown in Table 1. The expression of GPX1 in the group of cells treated with the control GPX1-directed siRNA was 28.4% of that in the control group, This suggests that there was nonspecific gene knockdown.

Table 1.

Relative expression of GPX1 mRNA.

Groups Control siRNA Scrambled siRNA Control
Relative expression (%) 28.4 ± 3.2 99.4 ± 4.8 100 ± 1.7

Expression of GPX1 protein in porcine spleen lymphocytes after siRNA transfection

The expression of the GPX1 protein in porcine spleen lymphocytes after siRNA transfection is shown in Fig. 2. That GPX1-knockdown cells expressed only 36.9% of the GPX1 expressed by the normal group. Therefore, the knockdown efficiency was 63.1%.

Figure 2.

Figure 2

Relative expression of GPX1 and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) proteins. Its show that there was no significant difference in the expression of GAPDH between the normal and knockdown groups. However, the expression of GPX1 differed significantly between the normal control and knockdown groups, and that GPX1-knockdown cells expressed only 36.9% of the GPX1 expressed by the normal group. Therefore, the knockdown efficiency was 63.1%. ##P < 0.01. Table 1. the expression of GPX1 in the group of cells treated with the control GPX1-directed siRNA was 28.4% of that in the control group, whereas the expression of GPX1 in the scrambled siRNA group was 99.4% of that in the control group. This suggests that there was no nonspecific gene silencing.

Antioxidant indices and ROS levels

The activities of SOD and CAT, the levels of GSH, hydrogen peroxide (H2O2), and malonaldehyde (MDA), the total antioxidant capacity (T-AOC), and the ability to inhibit free hydroxyl radicals are shown in Tables 28. The activities of SOD and CAT and the ability to inhibit free hydroxyl radicals were significantly lower in group M than in group P at most time points (P < 0.01); the level of GSH was significantly lower in group M than in group P at each time point, except at 6 h; and the levels of H2O2 and MDA were significantly higher in group M than in group P at each time point. Treatment with DON (0.824–0.103 μg/mL) alone reduced the activities of SOD and CAT, the levels of GSH and T-AOC, and the ability to inhibit free hydroxyl radicals significantly more strongly in group M than in the groups D1–4 at most time points; and the levels of H2O2 and MDA were significantly higher in the groups D1–4 than in group M. Treatment with Na2SeO3 (2 μmol/L) alone significantly increased the activities of SOD and CAT, T-AOC, and free hydroxyl radical inhibition relative to those in group M, except for GSH at 6 h. The levels of H2O2 and MDA were significantly lower in the groups D1–4 than in group M. When the lymphocytes were treated with both DON and Na2SeO3, the activities of SOD and CAT, the levels of GSH and T-AOC, and the inhibition of free hydroxyl radicals were significantly higher in group SD1–4 than in group D1–4 at most time points.

Table 3.

Effects of DON and/or Na2SeO3 on the levels of MDA in GPX1-knockdown porcine splenic lymphocytes at 6, 12, and 24 h after treatment.

MDA (nmol/mg.prot)
time pairing content P
6 h P — M 7.144 ± 0.027 7.584 ± 0.088 0.006
M — Se 7.584 ± 0.088 7.353 ± 0.060 0.005
M — D1 7.584 ± 0.088 10.276 ± 0.089 <0.001
M — D2 7.584 ± 0.088 8.812 ± 0.042 <0.001
M — D3 7.584 ± 0.088 8.114 ± 0.065 0.001
M — D4 7.584 ± 0.088 7.487 ± 0.066 0.017
D1 — SD1 10.276 ± 0.089 10.152 ± 0.132 0.037
D2 — SD2 8.812 ± 0.042 8.586 ± 0.127 0.045
D3 — SD3 8.114 ± 0.065 7.851 ± 0.072 <0.001
D4 — SD4 14.527 ± 0.632 7.348 ± 0.073 0.001
12 h P — M 7.573 ± 0.057 8.374 ± 0.098 0.001
M — Se 8.374 ± 0.098 8.108 ± 0.137 0.007
M — D1 8.374 ± 0.098 11.717 ± 0.195 <0.001
M — D2 8.374 ± 0.098 10.398 ± 0.161 <0.001
M — D3 8.374 ± 0.098 9.432 ± 0.086 <0.001
M — D4 8.374 ± 0.098 8.521 ± 0.074 0.009
D1 — SD1 11.717 ± 0.195 11.489 ± 0.270 0.034
D2 — SD2 10.398 ± 0.161 10.111 ± 0.190 0.003
D3 — SD3 9.432 ± 0.086 9.074 ± 0.198 0.031
D4 — SD4 8.521 ± 0.074 8.105 ± 0.186 0.023
24 h P — M 8.192 ± 0.109 9.207 ± 0.724 0.104
M — Se 9.207 ± 0.724 8.940 ± 0.082 0.546
M — D1 9.207 ± 0.724 12.872 ± 0.260 0.005
M — D2 9.207 ± 0.724 11.878 ± 0.245 0.011
M — D3 9.207 ± 0.724 11.011 ± 0.046 0.044
M — D4 9.207 ± 0.724 10.201 ± 0.160 0.093
D1 — SD1 12.872 ± 0.260 12.435 ± 0.235 0.001
D2 — SD2 11.878 ± 0.245 10.923 ± 0.274 <0.001
D3 — SD3 11.011 ± 0.046 10.327 ± 0.237 0.025
D4 — SD4 10.201 ± 0.160 9.439 ± 0.108 0.002

Table 4.

Effects of DON and/or Na2SeO3 on SOD activity in GPX1-knockdown porcine splenic lymphocytes at 6, 12, and 24 h after treatment.

SOD activities(U/mg.prot)
time pairing activities P
6 h P — M 52.592 ± 1.104 47.394 ± 0.872 0.001
M — Se 47.394 ± 0.872 48.646 ± 0.653 0.010
M — D1 47.394 ± 0.872 31.763 ± 0.340 <0.001
M — D2 47.394 ± 0.872 37.786 ± 0.272 0.001
M — D3 47.394 ± 0.872 44.982 ± 0.590 0.005
M — D4 47.394 ± 0.872 47.700 ± 0.816 0.011
D1 — SD1 31.763 ± 0.340 31.923 ± 0.399 0.042
D2 — SD2 37.786 ± 0.272 38.516 ± 0.657 0.082
D3 — SD3 44.982 ± 0.590 46.158 ± 0.565 <0.001
D4 — SD4 47.700 ± 0.816 49.241 ± 0.803 <0.001
12 h P — M 46.305 ± 0.566 43.505 ± 0.502 <0.001
M — Se 43.505 ± 0.502 45.169 ± 0.697 0.005
M — D1 43.505 ± 0.502 25.931 ± 0.364 <0.001
M — D2 43.505 ± 0.502 33.502 ± 0.307 <0.001
M — D3 43.505 ± 0.502 37.588 ± 0.596 <0.001
M — D4 43.505 ± 0.502 40.446 ± 0.595 <0.001
D1 — SD1 25.931 ± 0.364 26.253 ± 0.435 0.016
D2 — SD2 33.502 ± 0.307 34.266 ± 0.537 0.029
D3 — SD3 37.588 ± 0.596 38.659 ± 0.387 0.012
D4 — SD4 40.446 ± 0.595 43.253 ± 0.503 <0.001
24 h P — M 39.245 ± 0.427 32.629 ± 0.546 <0.001
M — Se 32.629 ± 0.546 33.907 ± 0.531 <0.001
M — D1 32.629 ± 0.546 16.264 ± 0.229 <0.001
M — D2 32.629 ± 0.546 18.606 ± 0.140 <0.001
M — D3 32.629 ± 0.546 21.386 ± 0.347 <0.001
M — D4 32.629 ± 0.546 25.740 ± 0.231 0.001
D1 — SD1 16.264 ± 0.229 16.870 ± 0.248 <0.001
D2 — SD2 18.606 ± 0.140 19.399 ± 0.368 0.026
D3 — SD3 21.386 ± 0.347 25.551 ± 0.500 <0.001
D4 — SD4 25.740 ± 0.231 30.201 ± 0.334 <0.001

Table 5.

Effects of DON and/or Na2SeO3 on the CAT activity in GPX1-knockdown porcine splenic lymphocytes at 6, 12, and 24 h after treatment.

CAT activities(U/mgprot)
time pairing activities P
6 h P — M 8.864 ± 0.060 8.132 ± 0.059 <0.001
M — Se 8.132 ± 0.059 8.212 ± 0.032 0.036
M — D1 8.132 ± 0.059 5.826 ± 0.029 <0.001
M — D2 8.132 ± 0.059 6.102 ± 0.029 <0.001
M — D3 8.132 ± 0.059 6.832 ± 0.033 <0.001
M — D4 8.132 ± 0.059 8.168 ± 0.111 0.357
D1 — SD1 5.826 ± 0.029 5.893 ± 0.019 0.007
D2 — SD2 6.102 ± 0.029 6.522 ± 0.006 0.001
D3 — SD3 6.832 ± 0.033 6.990 ± 0.013 0.005
D4 — SD4 8.168 ± 0.111 8.357 ± 0.109 <0.001
12 h P — M 8.594 ± 0.068 7.725 ± 0.037 <0.001
M — Se 7.725 ± 0.037 8.079 ± 0.077 0.004
M — D1 7.725 ± 0.037 4.858 ± 0.044 <0.001
M — D2 7.725 ± 0.037 5.628 ± 0.034 <0.001
M — D3 7.725 ± 0.037 6.185 ± 0.006 <0.001
M — D4 7.725 ± 0.037 7.448 ± 0.028 <0.001
D1 — SD1 4.858 ± 0.044 5.111 ± 0.020 0.012
D2 — SD2 5.628 ± 0.034 6.064 ± 0.007 0.001
D3 — SD3 6.185 ± 0.006 6.567 ± 0.036 0.002
D4 — SD4 7.448 ± 0.028 8.063 ± 0.059 0.001
24 h P — M 7.493 ± 0.054 6.206 ± 0.552 0.061
M — Se 6.206 ± 0.552 6.349 ± 0.057 0.707
M — D1 6.206 ± 0.552 3.545 ± 0.005 0.014
M — D2 6.206 ± 0.552 3.901 ± 0.027 0.019
M — D3 6.206 ± 0.552 4.480 ± 0.029 0.034
M — D4 6.206 ± 0.552 5.416 ± 0.024 0.138
D1 — SD1 3.545 ± 0.005 3.817 ± 0.020 0.001
D2 — SD2 3.901 ± 0.027 4.438 ± 0.047 <0.001
D3 — SD3 4.480 ± 0.029 5.289 ± 0.019 <0.001
D4 — SD4 5.416 ± 0.024 5.573 ± 0.036 0.002

Table 6.

Effects of DON and/or Na2SeO3 on the levels of GSH in GPX1-knockdown porcine splenic lymphocytes at 6, 12, and 24 h after treatment.

GSH (umol/gprot)
time pairing content P
6 h P — M 239.414 ± 6.165 233.345 ± 3.805 0.047
M — Se 233.345 ± 3.805 233.260 ± 4.220 0.757
M — D1 233.345 ± 3.805 142.407 ± 3.220 <0.001
M — D2 233.345 ± 3.805 168.664 ± 4.832 <0.001
M — D3 233.345 ± 3.805 204.520 ± 4.570 <0.001
M — D4 233.345 ± 3.805 226.293 ± 3.950 <0.001
D1 — SD1 142.407 ± 3.220 142.290 ± 3.005 0.446
D2 — SD2 168.664 ± 4.832 168.965 ± 4.895 0.015
D3 — SD3 204.520 ± 4.570 205.786 ± 4.415 0.005
D4 — SD4 226.293 ± 3.950 226.867 ± 4.311 0.110
12 h P — M 229.384 ± 5.665 222.599 ± 4.575 0.008
M — Se 222.599 ± 4.575 221.932 ± 5.550 0.358
M — D1 222.599 ± 4.575 126.747 ± 3.780 <0.001
M — D2 222.599 ± 4.575 153.548 ± 3.495 <0.001
M — D3 222.599 ± 4.575 179.396 ± 3.815 <0.001
M — D4 222.599 ± 4.575 198.856 ± 4.415 <0.001
D1 — SD1 126.747 ± 3.780 127.745 ± 2.195 0.389
D2 — SD2 153.548 ± 3.495 153.221 ± 1.760 0.772
D3 — SD3 179.396 ± 3.815 181.746 ± 2.890 0.048
D4 — SD4 198.856 ± 4.415 202.112 ± 3.990 0.006
24 h P — M 176.528 ± 2.395 165.320 ± 3.455 0.003
M — Se 165.320 ± 3.455 169.596 ± 2.640 0.012
M — D1 165.320 ± 3.455 97.760 ± 1.326 <0.001
M — D2 165.320 ± 3.455 113.939 ± 2.205 <0.001
M — D3 165.320 ± 3.455 133.746 ± 3.235 <0.001
M — D4 165.320 ± 3.455 148.813 ± 3.545 <0.001
D1 — SD1 97.760 ± 1.326 108.301 ± 2.090 0.002
D2 — SD2 113.939 ± 2.205 131.858 ± 3.510 0.002
D3 — SD3 133.746 ± 3.235 147.576 ± 2.850 <0.001
D4 — SD4 148.813 ± 3.545 156.226 ± 2.585 0.006

Table 7.

Effects of DON and/or Na2SeO3 on T-AOC in GPX1-knockdown porcine splenic lymphocytes at 6, 12, and 24 h after treatment.

T-AOC (U/mg.prot)
time pairing numerical P
6 h P — M 35.412 ± 0.445 32.571 ± 0.464 <0.001
M — Se 32.571 ± 0.464 32.749 ± 0.422 0.018
M — D1 32.571 ± 0.464 17.694 ± 0.257 <0.001
M — D2 32.571 ± 0.464 19.262 ± 0.233 <0.001
M — D3 32.571 ± 0.464 22.818 ± 0.189 <0.001
M — D4 32.571 ± 0.464 31.748 ± 0.386 0.003
D1 — SD1 17.694 ± 0.257 18.089 ± 0.259 <0.001
D2 — SD2 19.262 ± 0.233 19.759 ± 0.252 <0.001
D3 — SD3 22.818 ± 0.189 23.566 ± 0.324 0.011
D4 — SD4 31.748 ± 0.386 32.308 ± 0.343 0.002
12 h P — M 23.787 ± 0.314 20.108 ± 0.212 <0.001
M — Se 20.108 ± 0.212 21.821 ± 0.252 <0.001
M — D1 20.108 ± 0.212 9.731 ± 0.094 <0.001
M — D2 20.108 ± 0.212 10.618 ± 0.106 <0.001
M — D3 20.108 ± 0.212 14.833 ± 0.271 <0.001
M — D4 20.108 ± 0.212 17.613 ± 0.219 <0.001
D1 — SD1 9.731 ± 0.094 10.002 ± 0.139 0.009
D2 — SD2 10.618 ± 0.106 11.025 ± 0.111 <0.001
D3 — SD3 14.833 ± 0.271 15.449 ± 0.170 0.009
D4 — SD4 17.613 ± 0.219 19.087 ± 0.353 0.003
24 h P — M 15.915 ± 0.167 13.107 ± 0.169 <0.001
M — Se 13.107 ± 0.169 15.327 ± 0.184 <0.001
M — D1 13.107 ± 0.169 5.928 ± 0.064 <0.001
M — D2 13.107 ± 0.169 6.647 ± 0.079 <0.001
M — D3 13.107 ± 0.169 7.817 ± 0.089 <0.001
M — D4 13.107 ± 0.169 9.373 ± 0.095 <0.001
D1 — SD1 5.928 ± 0.064 6.374 ± 0.077 <0.001
D2 — SD2 6.647 ± 0.079 7.586 ± 0.090 <0.001
D3 — SD3 7.817 ± 0.089 9.350 ± 0.167 0.001
D4 — SD4 9.373 ± 0.095 11.210 ± 0.050 <0.001

Table 2.

Effects of DON and/or Na2SeO3 on the levels of H2O2 in GPX1-knockdown porcine splenic lymphocytes at 6, 12, and 24 h after treatment

H2O2 (mmol/gprot)
time pairing content P
6 h P — M 10.978 ± 0.387 13.964 ± 0.730 0.004
M — Se 13.964 ± 0.730 12.526 ± 0.422 0.015
M — D1 13.964 ± 0.730 19.719 ± 0.970 0.001
M — D2 13.964 ± 0.730 16.845 ± 0.269 0.008
M — D3 13.964 ± 0.730 15.823 ± 0.415 0.009
M — D4 13.964 ± 0.730 14.527 ± 0.632 0.010
D1 — SD1 19.719 ± 0.970 19.341 ± 1.271 0.162
D2 — SD2 16.845 ± 0.269 16.291 ± 0.732 0.174
D3 — SD3 15.823 ± 0.415 15.037 ± 0.324 0.004
D4 — SD4 14.527 ± 0.632 13.639 ± 0.283 0.048
12 h P — M 12.206 ± 0.513 17.757 ± 0.815 0.001
M — Se 17.757 ± 0.815 15.617 ± 0.689 0.001
M — D1 17.757 ± 0.815 30.445 ± 1.663 0.001
M — D2 17.757 ± 0.815 26.350 ± 1.513 0.002
M — D3 17.757 ± 0.815 23.882 ± 1.438 0.003
M — D4 17.757 ± 0.815 21.540 ± 1.633 0.015
D1 — SD1 30.445 ± 1.663 29.654 ± 1.513 0.012
D2 — SD2 26.350 ± 1.513 24.767 ± 1.168 0.015
D3 — SD3 23.882 ± 1.438 22.273 ± 0.784 0.051
D4 — SD4 21.540 ± 1.633 20.593 ± 0.816 0.182
24 h P — M 19.759 ± 0.973 25.341 ± 1.110 <0.001
M — Se 25.341 ± 1.110 22.547 ± 0.754 0.005
M — D1 25.341 ± 1.110 35.623 ± 1.581 0.001
M — D2 25.341 ± 1.110 32.710 ± 1.750 0.003
M — D3 25.341 ± 1.110 28.664 ± 1.372 0.002
M — D4 25.341 ± 1.110 27.633 ± 1.038 <0.001
D1 — SD1 35.623 ± 1.438 33.779 ± 1.384 0.004
D2 — SD2 32.710 ± 1.309 30.053 ± 1.268 0.011
D3 — SD3 28.664 ± 1.025 24.524 ± 1.082 0.002
D4 — SD4 27.633 ± 1.016 22.240 ± 1.120 <0.001

Table 8.

Effects of DON and/or Na2SeO3 on the cellular capacity to inhibit hydroxyl radicals in GPX1-knockdown porcine splenic lymphocytes at 6, 12, and 24 h after treatment.

The capacity of inhibing effect of hydroxyl radical (U/mg.prot)
time pairing numerical P
6 h P — M 192.734 ± 6.195 173.766 ± 4.325 0.003
M — Se 173.766 ± 4.325 177.184 ± 3.675 0.012
M — D1 173.766 ± 4.325 110.845 ± 3.445 <0.001
M — D2 173.766 ± 4.325 116.058 ± 2.265 <0.001
M — D3 173.766 ± 4.325 142.478 ± 3.595 <0.001
M — D4 173.766 ± 4.325 170.113 ± 4.335 <0.001
D1 — SD1 110.845 ± 3.445 111.664 ± 3.685 0.027
D2 — SD2 116.058 ± 2.265 117.824 ± 3.725 0.171
D3 — SD3 142.478 ± 3.595 146.309 ± 3.480 <0.001
D4 — SD4 170.113 ± 4.335 171.357 ± 3.805 0.056
12 h P — M 172.825 ± 3.715 148.956 ± 4.235 <0.001
M — Se 148.956 ± 4.235 156.173 ± 1.685 0.039
M — D1 148.956 ± 4.235 73.068 ± 1.841 <0.001
M — D2 148.956 ± 4.235 89.649 ± 1.747 0.001
M — D3 148.956 ± 4.235 118.062 ± 1.585 0.002
M — D4 148.956 ± 4.235 143.714 ± 3.145 0.014
D1 — SD1 73.068 ± 1.841 74.280 ± 2.008 0.006
D2 — SD2 89.649 ± 1.747 91.678 ± 2.932 0.097
D3 — SD3 118.062 ± 1.585 122.214 ± 2.665 0.022
D4 — SD4 143.714 ± 3.145 145.834 ± 2.895 0.005
24 h P — M 154.714 ± 3.225 130.376 ± 2.065 0.001
M — Se 130.376 ± 2.065 140.390 ± 2.380 <0.001
M — D1 130.376 ± 2.065 53.646 ± 2.155 <0.001
M — D2 130.376 ± 2.065 72.114 ± 2.847 <0.001
M — D3 130.376 ± 2.065 94.263 ± 1.722 <0.001
M — D4 130.376 ± 2.065 120.947 ± 2.861 0.002
D1 — SD1 53.646 ± 2.155 55.415 ± 1.853 0.010
D2 — SD2 72.114 ± 2.847 77.168 ± 1.659 0.018
D3 — SD3 94.263 ± 1.722 102.263 ± 2.389 0.002
D4 — SD4 120.947 ± 2.861 125.143 ± 2.625 0.001

The rates of change in SOD, CAT, GSH, H2O2, MDA, T-AOC, and the inhibition of free hydroxyl radicals are shown in Tables 915. Except in a few cases, most KG-An(the rates of change in the GPX1-knockdown porcine splenic lymphocytes with knockdown group An) are less than NG-An(the change rates of our early achievements were normal group An). The levels of ROS are shown in Table 16. The level of ROS was lowest in group P, whereas group D1 had the highest ROS content. The ROS content was significantly higher in group M than in group P. The ROS content was significantly higher in groups D1–4 than in group M, except for group D4. The ROS content was significantly lower in group Se than that in group M. When the cells were treated with both DON and Na2SeO3, the ROS content was significantly lower in the groups SD1–4 than in the groups D1–4, except for group SD1.

Table 10.

Rates of change in the MDA content of GPX1-knockdown porcine splenic lymphocytes and normal porcine splenic lymphocytes at 6, 12, and 24 h after treatment.

Groups The change rates of MDA(%)
6 h 12 h 24 h
KG-A1 −1.207 −1.946 −3.395
NG-A1 −2.442 −2.659 −5.212
KG-A2 −2.565 −2.760 −8.065
NG-A2 −3.550 −3.751 −9.448
KG-A3 −3.241 −3.785 −6.212
NG-A3 −4.470 −4.977 −9.614
KG-A4 −1.857 −4.882 −7.460
NG-A4 −2.937 −5.637 −10.618

Table 11.

Rates of change in the SOD activity of GPX1-knockdown porcine splenic lymphocytes and normal porcine splenic lymphocytes at 6, 12, and 24 h after treatment.

Groups The change rates of SOD(%)
6 h 12 h 24 h
KG-A1 0.504 1.241 3.726
NG-A1 0.620 1.549 4.307
KG-A2 1.923 2.279 4.263
NG-A2 2.106 2.419 5.496
KG-A3 2.614 2.848 19.475
NG-A3 2.980 3.065 24.023
KG-A4 3.231 6.887 17.331
NG-A4 3.086 4.978 25.139

Table 12.

Rates of change in the CAT activity in GPX1-knockdown porcine splenic lymphocytes and normal porcine splenic lymphocytes at 6, 12, and 24 h after treatment.

Groups The change rates of CAT(%)
6 h 12 h 24 h
KG-A1 1.150 5.208 7.673
NG-A1 5.345 5.780 9.308
KG-A2 6.867 7.676 13.740
NG-A2 8.320 9.964 18.559
KG-A3 2.313 6.176 18.058
NG-A3 10.657 12.255 19.103
KG-A4 2.301 8.257 2.899
NG-A4 2.222 10.774 12.278

Table 13.

Rates of change in the GSH content of GPX1-knockdown porcine splenic lymphocytes and normal porcine splenic lymphocytes at 6, 12, and 24 h after treatment.

Groups The change rates of GSH(%)
6 h 12 h 24 h
KG-A1 0.082 0.079 10.783
NG-A1 0.982 0.988 18.039
KG-A2 0.179 −0.213 15.727
NG-A2 1.615 1.598 18.957
KG-A3 0.619 1.310 29.742
NG-A3 1.883 1.861 10.293
KG-A4 0.254 1.637 4.981
NG-A4 2.013 2.078 8.850

Table 14.

Rates of change in the T-AOC of GPX1-knockdown porcine splenic lymphocytes and normal porcine splenic lymphocytes at 6, 12, and 24 h after treatment.

Groups The change rates of T-AOC(%)
6 h 12 h 24 h
KG-A1 2.226 2.788 7.521
NG-A1 2.493 3.161 9.560
KG-A2 2.575 3.837 14.126
NG-A2 2.999 4.893 17.197
KG-A3 3.276 4.155 19.611
NG-A3 3.531 5.866 26.060
KG-A4 1.176 8.369 19.599
NG-A4 1.391 9.268 27.709

Table 9.

Rates of change in the H2O2 contents of GPX1-knockdown porcine splenic lymphocytes and normal porcine splenic lymphocytes at 6, 12, and 24 h after treatment.

Groups The change rates of H2O2(%)
6 h 12 h 24 h
KG-A1 −1.917 −2.598 −5.176
NG-A1 −2.852 −3.877 −5.525
KG-A2 −3.289 −6.008 −8.123
NG-A2 −5.263 −7.281 −5.863
KG-A3 −4.968 −6.737 −14.443
NG-A3 −6.245 −8.660 −14.864
KG-A4 −12.160 −4.397 −19.517
NG-A4 −2.354 −5.215 −19.201

Table 15.

Rates of change in the capacities of GPX1-knockdown porcine splenic lymphocytes and normal porcine splenic lymphocytes to inhibit hydroxyl radicals at 6, 12, and 24 h after treatment.

Groups The change rates of inhibition of hydroxyl radical (%)
6 h 12 h 24 h
KG-A1 0.739 1.659 3.288
NG-A1 1.189 2.261 5.863
KG-A2 1.522 2.263 7.007
NG-A2 2.396 4.188 9.276
KG-A3 2.689 3.517 8.486
NG-A3 4.788 5.704 10.520
KG-A4 0.731 1.475 3.469
NG-A4 1.033 3.149 5.068

Table 16.

Effects of DON and/or Na2SeO3 on the levels of ROS in GPX1-knockdown porcine splenic lymphocytes at 24 h after treatment.

ROS content
Time pairing median P
24 h P — M 847.00 ± 42.00 1069.00 ± 52.00 0.001
M — Se 1069.00 ± 52.00 893.33 ± 22.50 0.009
M — D1 1069.00 ± 52.00 1426.33 ± 37.50 0.001
M — D2 1069.00 ± 52.00 1320.33 ± 41.50 0.001
M — D3 1069.00 ± 52.00 1241.33 ± 61.50 0.001
M — D4 1069.00 ± 52.00 1060.00 ± 67.00 0.408
D1 — SD1 1426.33 ± 37.50 1390.00 ± 27.00 0.027
D2 — SD2 1320.33 ± 41.50 1271.33 ± 47.50 0.005
D3 — SD3 1241.33 ± 61.50 1083.66 ± 95.00 0.015
D4 — SD4 1060.00 ± 67.00 1078.00 ± 45.00 0.276

Discussion

Oxidative stress occurs when the concentration of ROS exceeds the antioxidant capacity of the cell. When cells cultured in vitro are subjected to oxidative stress, they are mainly protected by the enzymes of their own antioxidant system, predominantly SOD, CAT, and GPX. GPX1 is the main GPX in spleen lymphocytes, and plays an important role in protecting the cells against oxidative stress. Using GSH as its substrate, GPX1 participates in the reduction of toxic peroxides, promotes the decomposition of H2O2, and thus protects the cell membrane. Yan25 knocked down the expression of GPX1 in ATDC5 cells with small hairpin RNA (shRNA), and found that the antioxidant capacity of the cells decreased. Our results are similar insofar as after GPX1 expression was reduced, the H2O2 content in group M increased as the incubation time increased, relative to that in group P, even at the beginning of silence that the SOD and CAT might compensate. The MDA and ROS content of group M was significantly higher than that of group P throughout the whole experiment (P < 0.01), whereas the GSH, SOD and CAT activities, T-AOC, and the capacity of the cells to inhibit hydroxyl radicals were significantly lower in group M. After GPX1 expression was knocked down in the porcine splenic lymphocytes, the antioxidant capacity of the cells decreased compared with that in group P, and the oxidative stress in the cells caused them more damage.

The presence of large amounts of lipids in cells makes them highly susceptible to peroxide and the damage caused by oxidative stress. The many lipid peroxidation products generated also have a toxic effect on the cells, causing further damage. The cellular levels of important lipid peroxidation products, including MDA, indicate the degree of lipid peroxidation and the amounts of free oxygen radicals in the cells, and can be used to indirectly determine the degree of oxidative damage to them26. When Kouadio et al.27 added 5–40 μM DON to the Caco-2 cell line, there was a significant increase in the MDA content after 24 h. Li28 also showed a significant increase in the MDA content after adding 100–2000 ng/mL DON to a chicken embryo fibroblasts (DF-1 cells) for 6–48 h. In the present study, the content of MDA in the GPX1-knockdown porcine splenic lymphocytes increased as the DON concentration and the culture period increased. Therefore, our results are similar to those of the studies described above. We compared the results of this experiment with the results of our experiment with prophase cells19. After treatment with DON, the MDA content in the GPX1-knockdown porcine splenic lymphocytes was significantly higher than in the normal porcine splenic lymphocytes, indicating that lipid peroxidation increased in the cells after GPX1 knockdown. After the addition of DON, the content of H2O2 was significantly higher in the GPX1-knockdown porcine splenic lymphocytes than in the normal porcine splenic lymphocytes because GPX1 decomposes H2O2 and thus reduces DON-induced oxidative stress. T-AOC reflects the overall antioxidant capacity of the cells and is a comprehensive indicator of the cells antioxidant system. In this study, the T-AOC of the GPX1-knockdown porcine splenic lymphocytes decreased as the DON concentration and the incubation time increased, and was significantly lower than that in the normal porcine splenic lymphocytes treated with the same concentrations of DON for the same culture periods (P < 0.01). The results of this study are similar to those of Hao et al.29. who added AFB1 to lymphocytes from the spleens of pigs in which GPX1 was knocked down. Therefore, DON causes the levels of MDA and H2O2 to increase and the cellular T-AOC to decrease more severely in GPX1-knockdown porcine splenic lymphocytes than in control cells. Our results also show that, compared with the normal porcine splenic lymphocytes, the capacity of the GPX1-knockdown cells to inhibit hydroxyl radicals decreased more dramatically as the DON concentration increased and the incubation time increased, resulting in a greater accumulation of free radicals, a greater degree of oxidative stress, a greater reduction in T-AOC, and therefore more-severe oxidative damage.

Oxidative damage occurs when the intracellular reactive oxygen concentration exceeds the cell’s antioxidant capacity. ROS mainly include superoxide anions (∙O2), H2O2, and the hydroxyl radical (−OH). Cells scavenge ROS through both enzymatic and non-enzymatic pathways. The enzymatic pathways consist of antioxidant enzymes such as SOD, CAT, and GPX, and the non-enzymatic pathways involve GSH, Se, vitamin C, vitamin E, and β-carotene30. SOD uses the superoxide anion (∙O2) produced in cells as its substrate, producing reduced SOD (SOD) and O2, and then SOD reacts with ∙O2 to produce SOD and H2O2. H2O2 is then catalysed by CAT and GPX to generate H2O and O231, thus protecting the cell membrane from damage. CAT is a terminal oxidase that catalyses the decomposition of H2O2 into H2O and O2. GSH is a co-substrate of GPX, which catalyses it to GSSG, thus reducing a toxic peroxide to a nontoxic hydroxyl compounds, and at the same time promoting the decomposition of H2O2. This protects the cell membrane structure and function are safe from the oxide interference and damage. Studies have shown that at lower GSH contents can result in decreased GPx1 activity32. Therefore, after reactive oxygen is produced in cells, SOD acts as the first line of defence and CAT and GPX as the second line of defence, acting together in the process of scavenging intracellular reactive oxygen. Our results show that DON caused the activities of SOD and CAT to increase, and reduced the levels of GSH as the DON concentration and incubation time increased, demonstrating the time and concentration dependence of its effects. The results of this study are similar to those of Gan et al.33, who showed that when the expression of the GPX1 protein was knocked down, the GSH content of the cells decreased significantly after ochratoxins (OTA) were added. When the results of the present study were compared with the results of our study of prophase cells19, the SOD and CAT activities and the levels of GSH were significantly lower in the GPX1-knockdown porcine splenic lymphocytes when same concentrations of DON were added and the cells were cultured for the same time. This may be because the cells themselves had a lower antioxidant capacity after GPX1 knockdown, and the intracellular accumulation of ROS and the consumption of antioxidant enzymes and GSH were increased by the cytotoxicity of DON and DON-induced oxidative stress.

Selenium is a necessary trace element in the diet of mammals because it plays an important role in many organ systems and life activities. The antioxidant effects of Se have always been a research hotspot, and it mainly occurs in selenocysteine and selenomethionine in selenoproteins, where it plays its antioxidant role. GPX is the main selenium antioxidant enzyme in cells34. GPX has at least four isoenzymes, and GPX1 is the most strongly expressed GPX in porcine splenic lymphocytes, where it plays an important role in ameliorating oxidative stress. In this study, after knocking down GPX1 expression, we added Na2SeO3 to the group M cells, and showed that the levels of MDA and H2O2 are significantly lower, and the activities of SOD and CAT, the levels of GSH and T-AOC, and the capacity to inhibit hydroxyl radicals were significantly higher than group M. These results are similar to the results of Tang35, who showed that Na2SeO3 had an antagonistic effect on GPX1-knockdown-induced oxidative damage to porcine splenic lymphocytes.

A large number of studies have shown that Se prevents the oxidative stress induced by some mycotoxins3638. In this study, the levels of MDA and H2O2 were significantly lower in the groups SD1–4 than in the groups D1–4 (P < 0.05 or P < 0.01), and the activities of SOD and CAT, the levels of GSH, T-AOC, and the capacity of the cells to inhibit hydroxyl radicals were higher in the groups SD1–4 than in the groups D1–4 mostly (P < 0.05 or P < 0.01). The rates of these changes in GPX1 knockdown porcine splenic lymphocytes were greater than in the normal porcine splenic lymphocytes, note the elevated ratio of the activities of SOD and CAT, the levels of GSH, T-AOC and the capacity of cells to inhibit hydroxyl radicals, the reduced ratio of the levels of MDA and H2O2 of GPx1 knockdown porcine splenic lymphocytes are lower than porcine splenic lymphocytes. These data indicate that the protective effects of Na2SeO3 against DON-induced oxidative damage were reduced by GPX1 knockdown.

In summary, our results demonstrate that the knockdown the GPX1 in porcine splenic lymphocytes reduces their anti-oxidative capacity, and the cells’ own oxidative stress causes them more damage than is caused in normal cells’. DON caused greater oxidative damage in GPX1-knockdown porcine splenic lymphocytes than in normal control cells. When combined with DON, Na2SeO3 ameliorated the DON-induced oxidative damage to GPX1-knockdown porcine splenic lymphocytes, but its protective effects were less marked than in normal cells. In the future, we will overexpress the GPX1 gene to in-depth study its effects, or to study spleen lymphocyte organelles. These studies are required to understand the molecular mechanisms underlying these phenomena. Our results also suggest that improved nutrition may be a novel approach to mitigating mycotoxin contamination in animal production.

Materials and Methods

Reagents

Foetal bovine serum was purchased from Gibco/Life Technologies (California, USA). Na2SeO3 powder was purchased from Xiya Reagent (Chengdu, China). DON was obtained from Sigma-Aldrich (USA). RPMI-1640 medium was obtained from Boster Biological Technology Co., Ltd (Wuhan, China). Hank’s solution and lymphocyte separation medium were obtained from Tianjin Hao Yang Biological Institute (China). Kits for testing glutathione(GSH), malonaldehyde (MDA), total antioxidant capacity (T-AOC), glutathione peroxidase (GPx), superoxide dismutase (SOD), catalase (CAT), hydrogen peroxide (H2O2), Hydroxyl Free Radical, were obtained from the Nanjing Jiancheng Bioengineering Institute (Nanjing, China). The Reactive Oxygen Species Assay Kit was obtained from Beyotime Biotechnology (Shanghai, China). TRIzol Reagent was purchased from Invitrogen Biotechnology Co., Ltd (Shanghai, China). PrimeScript™ RT Reagent Kit and SYBR® Premix Ex Taq™ II were purchased from Takara (Shiga, Japan). The anti-GPX1 primary antibody (ab50427) and the rabbit anti-goat IgG H& L secondary antibody (ab6741) were from abcam.

Production and treatment of porcine splenic lymphocytes and the establishment of GPX1-knockdown porcine spleen lymphocytes

For a description of the production of the porcine spleen lymphocytes, refer to our earlier paper24. All study procedures were approved by the Institutional Animal Care and Use Committee of Sichuan Agricultural University. All experiments were performed in accordance with relevant guidelines and regulations. Based on a published sequence of porcine GPX1 mRNA (GenBank NM-214201.0), siRNA was designed using Block-iTTM siRNA RNAi Designer (Thermo Fisher Scientific). The sequence with the highest score was selected, which had the control siRNA sequence 5′-GGGACUACACCCAGAUGAATT-3′. The scrambled siRNA was synthesized by Thermo Fisher Scientific, with the sequence 5′-UUCGUAUCUGGGUGUACCCTT-3′. The control siRNA sequence was confirmed to be consistent with that reported by Gan et al.33. The FAM fluorescent marker was added to the siRNA as required. RFectPM small nucleotide transfection agents was used for the transfection. To determine the optimal concentration of siRNA and transfection reagent, we tested four combinations, according to the reagent instructions. The specific information is shown in Table 17. The cells with the highest transfection efficiency were used for the subsequent experiments. The expression of GPX1 mRNA was detected with quantitative real-time PCR (qPCR) and the expression of GPX1 protein was detected 48 h after transfection with western blotting.

Table 17.

Concentrations of transfection reagent and siRNA.

Combination names
reagent 10 μL 12 μL 14 μL 16 μL
Positive siRNA(with FAM) GPx1 12 nmol/L 18 nmol/L 24 nmol/L 30 nmol/L

The prepared porcine spleen lymphocytes and GPX1-knockdown lymphocytes were cultured in triplicate in six-well tissue culture plates at 3 × 106 cells/mL. To determine the effects of DON and Se14,24, 11 groups of both types of cells were treated with medium only or with DON and/or Se in the following combinations: Group P (porcine splenic lymphocytes), group M (GPX1-knockdown porcine splenic lymphocytes), D1 (824 ng/mL DON), D2 (412 ng/mL DON), D3 (206 ng/mL DON), D4 (103 ng/mL DON), Se (2 μmol/L Na2SeO3), SD1 (2 μmol/L Na2SeO3 + 824 ng/mL DON), SD2 (2 μmol/L Na2SeO3 + 412 ng/mL DON), SD3 (2 μmol/L Na2SeO3 + 206 ng/mL DON), and SD4 (2 μmol/L Na2SeO3 + 103 ng/mL DON). The cells were incubated for 6, 12, or 24 h. The concentration of DON and Se and the time of cells were incubated have been determined in the early stage of the laboratory. And the antioxidant indices were determined at each time point. The levels of ROS were detected at 24 h.

Flow-cytometric determination of positive siRNA transfection efficiency

After transfection for 24 h, the cells were collected with centrifugation at 1800 r/min for 5 min at 4 °C. The supernatant, was discarded and the cells were washed twice with phosphate-buffered saline (PBS) at 4 °C. The PBS cell suspension (100 μL) was precooled to 4 °C and filtered through a 300 mesh filter. The cells were then analysed with flow cytometry.

Reverse transcription (RT)–qPCR analysis of GPX1 mRNA expression after siRNA transfection

For a description of the RT–qPCR performed, see the paper by Wang26. The primer sequencing for GPx1: (F- TGGGGAGATCCTGAATTG, R- GATAAACTTGGGGTCGGT) β-Actin was used as reference gence: (F- CTGCGGCATCCACGAAACT, R- AGGGCCGTGATCTCCTTCTG).

Detection of GPX1 protein with western blotting after transfection

The cells were washed twice with precooled PBS and suspended in 300 μL of PBS. The cells were collected and homogenized on ice, and phenylmethanesulfonyl fluoride was added to the protein lysates. After 40 min on ice, the lysates were centrifuged at 12,000 rpm for 40 min at 4 °C and the supernatants collected. The cellular protein was quantified with the BCA method using bovine serum albumin as the standard. Samples of protein (50 μg) were diluted in sample loading buffer and heated at 95 °C for 5 min. The denatured proteins were separated with 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), transferred onto polyvinylidene difluoride membrane, and placed in closed liquid for 1 h at 37 °C. The primary antibody was added and the membranes incubated at 4 °C. At the same time, another membrane was incubated without antibody in Tris-buffered saline containing Tween 20 (TBS-T) as the negative control. After repeated washes, the membrane was incubated with a rabbit anti-goat IgG H&L secondary antibody with gentle shaking for 1 h at room temperature. After the membrane was washed, used western blot mark to observe, the absorbance (A) values were quantitatively analysed with an image analysis.

Determination of antioxidant indices and levels of ROS

The antioxidant indices and the levels of ROS in the cell preparations (supernatants, cell lysates, and cells) were measured according to the protocols of the corresponding kits.

Statistical analysis

The test results are expressed as means standard ± deviations. Excel was used to preliminarily test and collate the results. The statistical software SPSS ver. 22 was used for later statistical analyses, and Duncan’s method was used for multiple comparisons. The rates of change in some antioxidant indices, including H2O2, MDA, SOD, CAT, GSH, T-AOC, and the inhibition of hydroxyl radicals, were calculated in the SD and Group D1–4s (as follows). To express the rates of change in the GPX1-knockdown porcine splenic lymphocytes with knockdown group An(KG-An), the change rates of our early achievements were normal group An(NG-An). The changes in the antioxidant indices after Na2SeO3 was added were calculated by comparing the absolute values of KG-An with NG-An, to determine whether Na2SeO3 was antagonistic to the porcine spleen lymphocyte by GPX1.

An=(SD14/D141)×100%(n=4)

Electronic supplementary material

Dataset (126KB, xls)

Acknowledgements

This study was supported by the National Natural Science Foundation of China (General Program, grant no. 31402269). We thank XG Du for his assistance with the experiments and to D Li for experimental material. We thank Janine Miller, PhD, from Liwen Bianji, Edanz Editing China (www.liwenbianji.cn/ac), for editing the English text of a draft of this manuscript.

Author Contributions

Z.H. Ren and Z.C. Zuo conceived the study. Y. Fan and Z. Zhang wrote the manuscript. C.X. Chen, X.M. Wang and Z.W. Xu conducted the real-time P.C.R. experiments, S.Z. Cao, X.P. Ma and L.H. Shen analysed the results, C.H. Chen and Y.C. Hu prepared the figures and tables, Z.Y. Zhou assisted with the RNA extractions. G.N. Peng, S.M. Yu, Z.J. Zhong and J.L. Deng conducted the western blotting experiments, and determined the antioxidant indices. All the authors have reviewed the manuscript.

Data Availability

All data generated or analysed are valid during this study, included in this published article (and its Supplementary Information files).

Competing Interests

The authors declare no competing interests.

Footnotes

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Zhihua Ren, Yu Fan, Zhuo Zhang and Chaoxi Chen contributed equally.

Electronic supplementary material

Supplementary information accompanies this paper at 10.1038/s41598-018-36149-x.

References

  • 1.Pronyk C, Cenkowski S, Abramson D. Superheated steam reduction of deoxynivalenol in naturally contaminated wheat kernels. Food Control. 2006;17:789–796. doi: 10.1016/j.foodcont.2005.05.004. [DOI] [Google Scholar]
  • 2.Rotter BA, Prelusky DB, Pestka JJ. Toxicology of deoxynivalenol (vomitoxin) Journal of Toxicology and Environmental Health. 1996;48:1–34. doi: 10.1080/009841096161447. [DOI] [PubMed] [Google Scholar]
  • 3.Pestka JJ, Smolinski AT. Deoxynivalenol: Toxicology and potential effects on humans. Journal of Toxicology and Environmental Health. 2005;8:39. doi: 10.1080/10937400590889458. [DOI] [PubMed] [Google Scholar]
  • 4.Zain ME. Impact of mycotoxins on humans and animals. Journal of Saudi Chemical Society. 2011;15:129–144. doi: 10.1016/j.jscs.2010.06.006. [DOI] [Google Scholar]
  • 5.Shifrin VI, Anderson P. Trichothecenemycotoxins trigger a ribotoxic stress response that activates c-Jun N-terminal kinase and p38 mitogen-activated protein kinase and induces apoptosis. Journal of Biological Chemistry. 1999;274:13985–13992. doi: 10.1074/jbc.274.20.13985. [DOI] [PubMed] [Google Scholar]
  • 6.Ueno Y, et al. Comparative toxicology of trichothec mycotoxins: inhibition of protein synthesis in animal cells. Journal of Biological Chemistry. 1973;74:285–296. [PubMed] [Google Scholar]
  • 7.Islam Z, Gray JS, Pestka JJ. p38 mitogen-activated protein kinase mediates IL-8 induction by the ribotoxin deoxynivalenol in human monocytes. Toxicology and Applied Pharmacology. 2006;213:235–244. doi: 10.1016/j.taap.2005.11.001. [DOI] [PubMed] [Google Scholar]
  • 8.Pestka JJ. Mechanisms of deoxynivalenol-Induced gene expression and apoptosis. Food Additives and Contaminants. 2008;25:1128–1140. doi: 10.1080/02652030802056626. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Mishra S, Dwivedi PD, Pandey HP, Das M. Role of oxidative stress in deoxynivalenol induced toxicity. Food and Chemical Toxicology. 2014;72:20–29. doi: 10.1016/j.fct.2014.06.027. [DOI] [PubMed] [Google Scholar]
  • 10.Ren ZH, et al. Combined effects of deoxynivalenol and zearalenone on oxidative injury and apoptosis in porcine splenic lymphocytes in vitro. Experimental and Toxicologic Pathology. 2017;69:612–617. doi: 10.1016/j.etp.2017.05.008. [DOI] [PubMed] [Google Scholar]
  • 11.Braca A, Sortino C, Politi M, Morelli I, Mendez J. Antioxidant activity of flavonoids from licania licaniaeflora. Journal of Ethnopharmacology. 2002;79:379–381. doi: 10.1016/S0378-8741(01)00413-5. [DOI] [PubMed] [Google Scholar]
  • 12.Thomson CD. Assessment of requirements for selenium and adequacy of selenium status: a review. European Journal of Clinical Nutrition. 2004;58:391–402. doi: 10.1038/sj.ejcn.1601800. [DOI] [PubMed] [Google Scholar]
  • 13.Niedzielski P, et al. Selenium species in selenium fortified dietary supplements. Food Chemistry. 2016;190:454–459. doi: 10.1016/j.foodchem.2015.05.125. [DOI] [PubMed] [Google Scholar]
  • 14.Ren F, Chen X, Hesketh J, Gan F, Huang K. Selenium promotes T-cell response to TCR-stimulation and ConA, but not PHA in primary porcine splenocytes. Plos One. 2012;7:e35375. doi: 10.1371/journal.pone.0035375. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Lin CG, et al. Effects of different selenium sources on growth performance, serum antioxidant capacity and plasma selenium content of weaned piglets. Chinese Journal of Animal and Veterinary Sciences. 2013;44:1790–1796. [Google Scholar]
  • 16.Rizzo AF, Atroshi F, Ahotupa M, Sankari S, Elovaara E. Protective effect of antioxidants against free radical-mediated lipid peroxidation induced by DON or T-2 toxin. Zentralbl Veterinarmed A. 2010;41:81–90. doi: 10.1111/j.1439-0442.1994.tb00070.x. [DOI] [PubMed] [Google Scholar]
  • 17.Peng SQ, et al. Toxic effects of deoxynovalenol on articular chondrocytes and the protective effect of Selenium. Chinese journal of Endemiology. 1994;13:80–82. [Google Scholar]
  • 18.Wang X, et al. Protective role of selenium in the activities of antioxidant enzymes in piglet splenic lymphocytes exposed to deoxynivalenol. Environmental Toxicology and Pharmacology. 2016;47:53–61. doi: 10.1016/j.etap.2016.09.003. [DOI] [PubMed] [Google Scholar]
  • 19.Ma S. Progress on GSH-Px and GST. Progress in Veterinary medicine. 2008;29:53–56. [Google Scholar]
  • 20.Miller JC, et al. Influence of the glutathione peroxidase 1 Pro200Leu polymorphism on the response of glutathione peroxidase activity to selenium supplementation: a randomized controlled trial. American Journal of Clinical Nutrition. 2012;96:923–931. doi: 10.3945/ajcn.112.043125. [DOI] [PubMed] [Google Scholar]
  • 21.Chen F, et al. Association of glutathione peroxidase-1 gene polymorphism with kawasaki disease. Chinese journal of arteriosclerosis. 2015;23:290–294. [Google Scholar]
  • 22.Moriscot C, Richard MJ, Favrot MC, Benhamou PY. Protection of insulin-secreting INS-1 cells against oxidative stress through adenoviral-mediated glutathione peroxidase overexpression. Diabetes and Metabolism. 2003;29:145–151. doi: 10.1016/S1262-3636(07)70021-6. [DOI] [PubMed] [Google Scholar]
  • 23.Shao S, et al. Effect of glutathione peroxidase 1 overexpression on DNA oxidative damage and phenotype of malignant BERP35T1 cells. Carcinogenesis Teratogenesis and Mutagenesis. 2016;28:8–13. [Google Scholar]
  • 24.Wang, X. M. et al. Protective role of selenium in immune-relevant cytokine and immunoglobulin production by piglet splenic lymphocytes exposed to deoxynivalenol. Biological Trace Element Research. 1–9 (2017). [DOI] [PubMed]
  • 25.Yan J, Guo Y, Yao F, Zhang R, Han Y. GPx1 knockdown suppresses chondrogenic differentiation of ATDC5 cells through induction of reductive stress. Acta Biochimica et Biophysica Sinica. 2017;49:110–118. doi: 10.1093/abbs/gmw125. [DOI] [PubMed] [Google Scholar]
  • 26.Larsen M, et al. Mannitol in cardioplegia as an oxygen free radical scavenger measured by malondialdehyde. Perfusion. 2002;17:51–55. doi: 10.1191/0267659102pf528oa. [DOI] [PubMed] [Google Scholar]
  • 27.Kouadio JH, et al. Comparative study of cytotoxicity and oxidative stress induced by deoxynivalenol, zearalenone or fumonisin B1 in human intestinal cell line Caco-2. Toxicology. 2005;213:56–65. doi: 10.1016/j.tox.2005.05.010. [DOI] [PubMed] [Google Scholar]
  • 28.Li D, et al. Evaluation of deoxynivalenol-induced toxic effects on DF-1 cells in vitro: cell-cycle arrest, oxidative stress, and apoptosis. Environmental Toxicology and Pharmacology. 2014;37:141–149. doi: 10.1016/j.etap.2013.11.015. [DOI] [PubMed] [Google Scholar]
  • 29.Hao S, et al. Selenium alleviates Aflatoxin B1-induced immune toxicity through improving glutathione peroxidase 1 and selenoprotein S expression in primary porcine splenocytes. Journal of Agricultural and Food Chemistry. 2016;64:1385. doi: 10.1021/acs.jafc.5b05621. [DOI] [PubMed] [Google Scholar]
  • 30.Zhang KF, Zhang ZP, Chen Y, Lin P, Wang YL. Antioxidant defense system in animals. Chinese journal of Zoology. 2007;42:153–160. doi: 10.1086/tcj.57.20066249. [DOI] [Google Scholar]
  • 31.Chen HP, Tan XF. Literature review of researches on superoxide dismutase. Nonwood Forest Research. 2007;25:59–65. [Google Scholar]
  • 32.Dragomir-Bodea GO, et al. Influence of deoxynivalenol on the oxidative status of HepG2 cells. Romanian Biotechnological Letters. 2009;14:4349–4359. [Google Scholar]
  • 33.Gan F, Xue H, Huang Y, Pan C, Huang K. Selenium alleviates porcine nephrotoxicity of ochratoxin A by improving selenoenzyme expression in vitro. Plos One. 2015;10:e0119808. doi: 10.1371/journal.pone.0119808. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Xu F, Qiu DR, Yang PY. Chemical and biochemical speciation of Se proteins. Chemical world. 2006;47:246–250. [Google Scholar]
  • 35.Tang R, Liu H, Wang T, Huang H. Mechanisms of selenium inhibition of cell apoptosis induced by oxysterols in rat vascular smooth muscle cells. Archives of Biochemistry and Biophysics. 2005;441:16–24. doi: 10.1016/j.abb.2005.06.006. [DOI] [PubMed] [Google Scholar]
  • 36.Fang J, et al. The molecular mechanisms of protective role of Se on the G2/M phase arrest of jejunum caused by AFB1. Biological Trace Element Research. 2017;181:1–12. doi: 10.1007/s12011-017-1030-2. [DOI] [PubMed] [Google Scholar]
  • 37.Van-Le-Thanh B, et al. The potential effects of antioxidant feed additives in mitigating the adverse effects of corn naturally contaminated with Fusarium mycotoxins on antioxidant systems in the intestinal mucosa, plasma, and liver in weaned pigs. Mycotoxin Research. 2016;32:1–18. doi: 10.1007/s12550-016-0245-y. [DOI] [PubMed] [Google Scholar]
  • 38.Jie Y, Chen DW, Bing B. Protective effects of selenium and vitamin E on rats consuming maize naturally contaminated with mycotoxins. Frontiers of Agriculture in China. 2009;3:95–99. doi: 10.1007/s11703-009-0015-0. [DOI] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Dataset (126KB, xls)

Data Availability Statement

All data generated or analysed are valid during this study, included in this published article (and its Supplementary Information files).


Articles from Scientific Reports are provided here courtesy of Nature Publishing Group

RESOURCES